DXB 3.92% 53.0¢ dimerix limited

$2, page-27

  1. 1,582 Posts.
    lightbulb Created with Sketch. 105
    Conservative as it should be for a 12 month target.

    Long term one needs to calculate the value of 15%+ royalties earned in a $3+B market without a viable competing drug for 10 years.

    i.e. $450,000+ per annum.

    Hell, be conservative and assume all the milestone payments only cover off all of the costs of commercialization and ongoing ops.

    $4.5B plus in royalties.

    Big numbers.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
53.0¢
Change
0.020(3.92%)
Mkt cap ! $291.6M
Open High Low Value Volume
51.0¢ 53.8¢ 51.0¢ $782.0K 1.490M

Buyers (Bids)

No. Vol. Price($)
1 6408 53.0¢
 

Sellers (Offers)

Price($) Vol. No.
53.5¢ 35657 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.